Epidemiology of osteoarthritis in Karelian Republic and effectiveness of symptom modifying slow-actions remedies in the treatment of disease
- Authors: Vezikova N.N.1,2, Ignatiev V.K.1,2, Svetlova M.S.1,2
-
Affiliations:
- Karelian scientific-medical center NWB RAMS
- Petrozavodsk State University
- Issue: Vol 3, No 4 (2003)
- Pages: 71-76
- Section: Clinical medicine
- Published: 25.11.2003
- URL: https://journals.eco-vector.com/MAJ/article/view/693775
- ID: 693775
Cite item
Abstract
Epidemiology and diseaseness of osteoarthritis were valued in Karelian Republic during 1998-2000 years as on the republic as a whole, so and jn the regions of republic. Unceasing growing of osteoarthritis diseaseness are observed. With 1998 to 2000 years the epidemiology is enlarge in absolute numerals on 28,8%, the diseaseness is enlarge on 40%. At the collation with similar to given on Russia is reveal that general and primary diseaseness of osteoarthritis in Karelia above, than on Russia at the average. There are differences of epidemiology data on regions of republic, that is stipulate different climatic and industrial conditions, but in the same way level of rendering a medical help.
Studied efficiency and safety of symptom-modifying slow-actions remedies beside sick with osteoarthritis. The therapy of chondroitin-sulphate (CS) are gave 34 patients, glucosaeamin-hydrochloride (GH) - 30, mainly women, average age more than 53 years, duration of disease more than 6 years, I and II rentgeno- logical stage of OA, Leken's index was more 4 and less 14. Reveal that therapy CS and GH brings about reducing of pains at rest and under step, to reducing a functional index of Leken, reducing a need for NSAI. Clinical significant effect is saved within 6 months. At the therapy of CS and GH is not reveal side effects, required cancelling data a remedies or additional treatment.
Growing of general and primary diseaseness of OA must come into notice physicians for the reason the early diagnostics and in good time commenced treatments of symptom modifying slow-actions remedies of CS and GH.
About the authors
N. N. Vezikova
Karelian scientific-medical center NWB RAMS; Petrozavodsk State University
Author for correspondence.
Email: shabanov@mail.rcom.ru
Russian Federation, Petrozavodsk; Petrozavodsk, 185019
V. K. Ignatiev
Karelian scientific-medical center NWB RAMS; Petrozavodsk State University
Email: shabanov@mail.rcom.ru
Russian Federation, Petrozavodsk; Petrozavodsk, 185019
M. S. Svetlova
Karelian scientific-medical center NWB RAMS; Petrozavodsk State University
Email: shabanov@mail.rcom.ru
Russian Federation, Petrozavodsk; Petrozavodsk, 185019
References
- Алексеева Л. И. Современные представления о диагностике и лечении остеоартроза // РМЖ. 2000. Т. 8. № 9. С. 377-382.
- Насонов Е. Л., Алексеева Л. И. Хондроитин сульфат (Структум) при лечении остеоартроза: патогенетическое обоснование и клиническая эффективность // Тер. архив. 2001. № 11. С. 87-89.
- Насонова В. А., Фоломеева О. М. Медико-социальное значение XIII класса болезней для населения России // Научно-практическая ревматология. 2001. № 1. С. 7-11.
- Фоломеева О. М., Амирджанова В. Н, Якушева Е. О. и др. Заболеваемость населения России ревматическими болезнями (анализ за 10 лет) // Тер. архив. 2002. № 5. С. 5-11.
- Цурко В. В., Хитров Н. А. Остеоартроз // Тер. архив. 2000. №5. С. 62-66.
- Шишкин В. И., Кудрявцева Г. В., Рябков А. Б. Действие препарата Структум (хондроитин сульфат) на биоэнергетические характеристики синовиальной жидкости при остеоартрозе // Научно-практическая ревматология. 2001. № 5. С. 34-38.
- Canapp S. O., McLaughlin R. М., Hoskinson et al. Scintigraphic evaluation of dogs with acute synovitis after treatment with glucosamine hydrochloride and chondroitin sulfate // Am. J. Vet Res. 1999. Vol. 60 (12). P. 1552-1557.
- McAlindon T. E., Lavalley M. P., Gulin J. P. et al. Glucosamin and chondroitin for treatment of osteoarthritis; a systematic guality assessment and meta-analysis // JAMA. 2000. Vol. 283. P. 1469-1475.
- Qiu G. X., Gao S. N., Giacovelli G., Rovati L. et al. Efficacy and safety of Glucosamine sulfate versuse ibuprofen in patients with knee ostejartritis // Arzneimittel-Fofschung. 1998. Vol. 48 (5). P. 469-474.
- Refinster J. Y, Deroisy, Paul L et al. Glucosamine sulfate significantly reduces progression of knee osteoarthritis over 3 years: a large, randomized, placebo-controlled, doule-blind, prospective trial // Arthritis Rheum. 1999. Vol. 42. P. 400.
- Uebelhart D., Thonar E. J., Zhang J. et al. Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbit // Osteoarthritis Cartilage. 1998. Vol. 6. P. 6-13.
Supplementary files
